Sign In
Buy PACB
$1.45
-0.180 (-11.04%)
At Close: Jun 05, 2026
Investors Heavily Search Pacific Biosciences of California, Inc. (PACB): Here is What You Need to Know
10:01am, Thursday, 02'nd May 2024
Pacific Biosciences (PACB) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Here's Why Pacific Biosciences (PACB) is Poised for a Turnaround After Losing -63.44% in 4 Weeks
10:36am, Thursday, 25'th Apr 2024
Pacific Biosciences (PACB) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts i
Pacific Biosciences (PACB) Upgraded to Buy: Here's What You Should Know
01:00pm, Tuesday, 23'rd Apr 2024
Pacific Biosciences (PACB) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
PacBio (PACB) Preliminary Q1 Revenues Dampened by Purchase Delays
02:01pm, Wednesday, 17'th Apr 2024
PacBio's (PACB) revenue growth in the first quarter is likely to have been hampered by an increasing number of customers delaying instrument purchases and softness in consumable shipments.
The Cathie Wood Stock Shuffle: 4 Names She's Loving, 3 She's Leaving
02:47pm, Tuesday, 16'th Apr 2024
At one point Cathie Wood was the hottest money manager on Wall Street. Her family of Ark Invest exchange-traded funds (ETF) grew at a blistering pace, at one point doubling the returns for investors.
PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance
08:05am, Tuesday, 16'th Apr 2024
Announces Plan to Reduce Annualized Operating Expense Run Rate by $50 - $75 Million Q1 2024 Earnings Conference Call Scheduled for May 9, 2024 MENLO PARK, Calif. , April 16, 2024 /PRNewswire/ – Pa
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now
11:56am, Wednesday, 03'rd Apr 2024
PacBio's (PACB) strong product demand and top-line growth raise optimism about the stock.
Estonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes
08:00am, Wednesday, 27'th Mar 2024
HiFi Data Generated on the Revio™ System will Support the EU and Estonian Government-Funded Center for Personalized Medicine and Unlock Discoveries Across Cardiology, Mental and Reproductive Healt
PacBio Grants Equity Incentive Award to New Employee
04:30pm, Friday, 22'nd Mar 2024
MENLO PARK, Calif., March 22, 2024 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of t
Pacific Biosciences' Pivot: From Shareholder Dilution To Expansion And Leadership
12:42pm, Tuesday, 19'th Mar 2024
PacBio expands product adoption, introducing Revio and Onso, enhancing market and technological reach. Despite 10% growth since 2015, dilution eroded shareholder value; pivot possible with 25% growth
Top 5 Health Care Stocks Which Could Rescue Your Portfolio In March - Inspire Veterinary (NASDAQ:IVP), Fractyl Health (NASDAQ:GUTS)
08:08am, Tuesday, 19'th Mar 2024
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
PacBio's (PACB) New Panel to Aid Its Clinical Research Solution
11:21am, Wednesday, 13'th Mar 2024
PacBio (PACB) announces the PureTarget repeat expansion panel, which is the HiFi long-read sequencing that supports comprehensive analysis of 20 genes associated with neurological diseases.
PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions
09:05am, Tuesday, 12'th Mar 2024
HiFi Long-Read Sequencing Panel Supports Comprehensive Analysis of 20 Genes Associated With Neurological Disease MENLO PARK, Calif. , March 12, 2024 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading d
PacBio (PACB) Q4 Earnings Beat, Adjusted Gross Margin Down
11:51am, Friday, 16'th Feb 2024
PacBio (PACB) witnesses strong revenue growth in the fourth quarter, partly aided by customers' continued product transition to the Revio system.
Pacific Biosciences (PACB) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
07:31pm, Thursday, 15'th Feb 2024
While the top- and bottom-line numbers for Pacific Biosciences (PACB) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key me
